Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
May 06, 2026
Marriott International (MAR): Q1 2026 Earnings Preview and What Investors Should Watch

Marriott International (MAR): Q1 2026 Earnings Preview and What Investors Should Watch

Key Takeaways

  • Analysts expect Q1 2026 adjusted EPS of $2.55-$2.60, up about 12% from $2.32 in Q1 2025.
  • Consensus revenue forecast stands at $6.58-$6.59 billion, reflecting 5.3% year-over-year growth.
  • Company guidance for Q1 adjusted EPS is $2.50-$2.55, slightly below consensus but aligned with full-year outlook of $11.32-$11.57.
  • Global RevPAR (revenue per available room) expected to rise 1-2%, driven by international leisure demand.
  • Investors watching franchise fees, luxury segment performance, and net room growth amid steady portfolio expansion.
  • Stock up over 14% YTD in 2026, reflecting optimism in travel recovery and credit card fee boosts.

Earnings Context and Why It Matters

As the world's largest hotel chain by room count, Marriott International (MAR) runs an asset-light model centered on franchising and management fees. This Q1 2026 earnings report, set for May 6 before the market opens, marks the first real look at 2026 performance after a solid 2025. Worldwide RevPAR grew 2% last year, with international markets up 5.1% helping to offset softer U.S. demand. From what I see, this report is key for tracking the travel demand recovery, luxury segment strength, and the lift from higher co-branded credit card royalties, all of which could push fee revenue higher. In an uncertain economy, an EPS beat or strong guidance might justify MAR's premium valuation, while any RevPAR slowdown could point to ongoing U.S. transient challenges.

Earnings Expectations

Wall Street's consensus calls for Q1 2026 adjusted EPS of $2.55 to $2.60, roughly 12% above the $2.32 from Q1 2025. That lines up closely with Marriott's own guidance of $2.50 to $2.55, shared during Q4 2025 earnings. Revenue is projected at $6.58 billion to $6.59 billion, a 5.3% increase from about $6.26 billion a year ago, driven by unit growth and modest RevPAR improvements.

One thing that stands out is global RevPAR, guided for 1-2% growth, led by international leisure and cross-border travel. Franchise and incentive management fees, a major revenue pillar, drew support from the record 610,000-room pipeline at the end of 2025. For the full year 2026, the company has reaffirmed adjusted EPS guidance of $11.32-$11.57—up around 15% from 2025's $9.51—and worldwide RevPAR growth of 1.5-2.5%, backed by 4.5-5% net room growth and elevated credit card royalties. I also checked this using Tickeron’s AI Screener to gauge how MAR stacks up against peers in hospitality.

Historically, MAR has beaten EPS estimates in three of the last four quarters, and the stock has tended to respond well to robust international RevPAR and development news. In Q4 2025, adjusted EPS came in at $2.58—a slight miss—but revenue hit $6.69 billion, a beat that sent shares up 8.5%.

Market Reaction and Investor Sentiment

Heading into this report, sentiment around MAR feels cautiously optimistic, with shares up over 14% year-to-date in 2026 following a strong 2025. Investors seem to expect an EPS and fee beat, though they're keeping a close eye on U.S. RevPAR amid government spending pressures and softness in the select-service segment. Risks like shifts in Easter and Chinese New Year timing could weigh on comparisons. Typically, MAR stock moves 3-5% after earnings, with gains tied to international strength and steady guidance.

Why I Rely on Tickeron’s AI Screener

In my own research, I turn to Tickeron’s AI Screener as a powerful tool for discovering stocks and ETFs. It lets me filter thousands of names using technical patterns, fundamentals, trends, volatility, and AI signals—customized by industry, market cap, indicators, price patterns, or performance metrics. This helps spot trade ideas, breakouts, and opportunities far faster than manual scans. I've found it especially useful for digging into hospitality names like MAR and comparing them across the sector.

Forward Outlook and Key Factors to Monitor

After Q1 results, I'll be watching updates on full-year guidance, especially RevPAR trends and net room growth. Marriott's 610,000-room pipeline—half of it international—underpins 4.5-5% expansion, with conversions making up about one-third of signings. Luxury RevPAR, which rose over 6% in Q4 2025, continues to shine thanks to resilient high-end demand.

Co-branded credit card fees should see 8-10% gross fee revenue growth from renegotiated royalties, bolstering margins in this asset-light setup. Adjusted EBITDA guidance of $5.84-$5.93 billion points to 8-10% growth, paired with over $4.3 billion in planned shareholder returns.

Looking ahead, catalysts like the 2026 FIFA World Cup (a 30-35 bps RevPAR boost) and AI-driven distribution deals are worth noting. Keep an eye on demand breakdowns—leisure and group versus business transient—along with regional standouts in APAC and EMEA. Cost headwinds from tech and labor investments may pressure margins, but the fee leverage offers some protection. I'm watching these closely to gauge the 2026 path.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MAR

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


MAR in upward trend: 10-day moving average broke above 50-day moving average on October 02, 2026

The 10-day moving average for MAR crossed bullishly above the 50-day moving average on October 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 16, 2026. You may want to consider a long position or call options on MAR as a result. In 49 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 58%.

The Moving Average Convergence Divergence (MACD) for MAR just turned positive on September 15, 2026. Looking at past instances where MAR's MACD turned positive, the stock continued to rise in 35 of 51 cases over the following month. The odds of a continued upward trend are 69%.

MAR moved above its 50-day moving average on September 28, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +2.72% 3-day Advance, the price is estimated to grow further. Considering data from situations where MAR advanced for three days, in 213 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

Bearish Trend Analysis

The 10-day RSI Indicator for MAR moved out of overbought territory on September 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 51 similar instances where the indicator moved out of overbought territory. In 28 of the 51 cases, the stock moved lower in the following days. This puts the odds of a move lower at 55%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MAR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 49%.

MAR broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MAR entered a downward trend on September 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 5 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 14 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 66, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. MAR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MAR's P/B Ratio (443.634) is very high in comparison to the industry average of (43.305). P/E Ratio (37.119) is within average values for comparable stocks, (44.567). Projected Growth (PEG Ratio) (1.793) is also within normal values, averaging (20.230). Dividend Yield (0.008) settles around the average of (0.019) among similar stocks. P/S Ratio (3.341) is also within normal values, averaging (2.766).

Notable companies

The most notable companies in this group are Marriott International (NASDAQ:MAR), Hilton Worldwide Holdings (NYSE:HLT), H World Group Limited (NASDAQ:HTHT).

Industry description

Companies that operate paid and subscriber-based broadcast facilities for cable and home satellite systems. Comcast Corp, Charter Communications, Inc. and DISH Network Corporation are some of the biggest cable/satellite TV providers. Customers typically pay a regular monthly fee to cable TV operators for unlimited access to a certain package of channels. Since the rising popularity of online streaming services have increased instances of cord-cutting among consumers, several cable operators have also diversified into internet services to milk the burgeoning appetite for internet-based content.

Market Cap

The average market capitalization across the Cable/Satellite TV Industry is 21.11B. The market cap for tickers in the group ranges from 196.44K to 93.5B. MAR holds the highest valuation in this group at 93.5B. The lowest valued company is UOKA at 196.44K.

High and low price notable news

The average weekly price growth across all stocks in the Cable/Satellite TV Industry was -3%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was -5%. CVEO experienced the highest price growth at 1%, while INTG experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the Cable/Satellite TV Industry was 1%. For the same stocks of the Industry, the average monthly volume growth was 40% and the average quarterly volume growth was -44%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 32
Price Growth Rating: 55
SMR Rating: 42
Profit Risk Rating: 65
Seasonality Score: 51 (-100 ... +100)
View a ticker or compare two or three
MAR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an operator of hotels and related lodging facilities

Industry CableSatelliteTV

Industry
Hotels Or Resorts Or Cruiselines
Address
7750 Wisconsin Avenue
Phone
+1 301 380-3000
Employees
414000
Web
https://www.marriott.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.
I've always appreciated how Mastercard (MA) maintains a commanding position in the global payments industry, processing transactions across 3.4 billion cards at 150 million merchant locations worldwide. The network effects here create a formidable moat—increased adoption by issuers, acquirers, and consumers just reinforces its dominance. What stands out to me is how Mastercard is evolving beyond a pure processor into a services-first platform. Value-added services (VAS)—covering cybersecurity, data analytics, and consulting—are now approaching 40% of revenues and growing at double the rate of traditional payments.
MU shares are declining approximately -6.00% in premarket trading on April 2, 2026, pulling back to roughly $353.70 from the prior session's close of $376.27. The primary catalyst is a sweeping new round of tariff announcements from the Trump administration, dubbed by markets as "Liberation Day 2.0," which has sparked a broad risk-off selloff across technology and semiconductor stocks